The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer

Colorectal cancer (CRC) is the third most deadly cancer worldwide, and inflammatory bowel disease (IBD) is one of the critical factors in CRC carcinogenesis. IBD is responsible for an unphysiological and sustained chronic inflammation environment favoring the transformation. MicroRNAs (miRNAs) belon...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences Vol. 22; no. 8; p. 3967
Main Authors: Bocchetti, Marco, Ferraro, Maria Grazia, Ricciardiello, Filippo, Ottaiano, Alessandro, Luce, Amalia, Cossu, Alessia Maria, Scrima, Marianna, Leung, Wing-Yan, Abate, Marianna, Stiuso, Paola, Caraglia, Michele, Zappavigna, Silvia, Yau, Tung On
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 12-04-2021
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer (CRC) is the third most deadly cancer worldwide, and inflammatory bowel disease (IBD) is one of the critical factors in CRC carcinogenesis. IBD is responsible for an unphysiological and sustained chronic inflammation environment favoring the transformation. MicroRNAs (miRNAs) belong to a class of highly conserved short single-stranded segments (18-25 nucleotides) non-coding RNA and have been extensively discussed in both CRC and IBD. However, the role of miRNAs in the development of colitis-associated CRC (CAC) is less clear. The aim of this review is to summarize the major upregulated (miR-18a, miR-19a, miR-21, miR-31, miR-155 and miR-214) and downregulated (miR-124, miR-193a-3p and miR-139-5p) miRNAs in CAC, and their roles in genes' expression modulation in chronic colonic-inflammation-induced carcinogenesis, including programmed cell-death pathways. These miRNAs dysregulation could be applied for early CAC diagnosis, to predict therapy efficacy and for precision treatment.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms22083967